This report provides a comprehensive analysis of the global Perfluorodecalin for Ophthalmic Surgery market, projecting significant growth through 2032. It examines the industry's landscape, focusing on the use of this non-toxic liquid for eyeball protection during surgical procedures. The study segments the market by purity levels and applications across hospitals and clinics, while offering detailed regional insights for the Americas, APAC, and Europe. Key industry players, including Bausch + Lomb and Alchimia srl, are evaluated alongside emerging market trends and competitive strategies.

Market Overview

The global Perfluorodecalin for Ophthalmic Surgery market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate throughout the forecast period.

Product Description

Perfluorodecalin for ophthalmic surgery is a perfluorocarbon aromatic organic compound. At room temperature, it is characterized as a colorless, odorless, and non-toxic liquid possessing both a low boiling point and a high boiling point. Its primary clinical utility is to fix and protect the eyeball during ophthalmic surgical procedures.

Regional Market Analysis

• United States: The market for Perfluorodecalin for Ophthalmic Surgery in the United States is expected to see consistent growth from 2025 through 2032.
• China: The Chinese market is projected to expand steadily over the forecast period from 2025 to 2032.
• Europe: The European market is estimated to undergo continuous growth between 2025 and 2032.

Market Segmentation

By Type

• Purity ≥ 95%
• Purity ≥ 97%

By Application

• Hospital
• Clinic
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Alchimia srl
• Bausch + Lomb
• BVI Medical
• Geuder AG
• Pharmpur
• Toomac Ophthalmic
• Micromed srl

Market Concentration

In 2025, the global market landscape was characterized by a significant concentration of market share held by the two largest companies.

Report Scope and Methodology

This research report by LP Information, Inc. (LPI), titled “Perfluorodecalin for Ophthalmic Surgery Industry Forecast,” provides a comprehensive analysis of the global industry. The study reviews total global sales for 2025 and offers a detailed analysis of projected sales for the period from 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

The Insight Report highlights:

• Key trends related to product segmentation, company formation, revenue, and market share.
• Latest developments and M&A activity.
• Strategic analysis of leading global companies, focusing on their Perfluorodecalin for Ophthalmic Surgery portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Market drivers, trends, and affecting factors shaping the global outlook.
• Emerging pockets of opportunity identified through a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs.

Key Questions Addressed

• What is the 10-year outlook for the global Perfluorodecalin for Ophthalmic Surgery market?
• What factors are driving Perfluorodecalin for Ophthalmic Surgery market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Perfluorodecalin for Ophthalmic Surgery market opportunities vary by end market size?
• How does Perfluorodecalin for Ophthalmic Surgery break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Perfluorodecalin for Ophthalmic Surgery by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Perfluorodecalin for Ophthalmic Surgery by Country/Region, 2021, 2025 & 2032

  • 2.2 Perfluorodecalin for Ophthalmic Surgery Segment by Type

    • 2.2.1 Purity ≥ 95%

    • 2.2.2 Purity ≥ 97%

    • 2.2.3 Perfluorodecalin for Ophthalmic Surgery Sales by Type

      • 2.2.3.1 Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Perfluorodecalin for Ophthalmic Surgery Sale Price by Type (2021-2026)

  • 2.3 Perfluorodecalin for Ophthalmic Surgery Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Others

    • 2.3.4 Perfluorodecalin for Ophthalmic Surgery Sales by Application

      • 2.3.4.1 Global Perfluorodecalin for Ophthalmic Surgery Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Perfluorodecalin for Ophthalmic Surgery Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Perfluorodecalin for Ophthalmic Surgery Breakdown Data by Company

    • 3.1.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales by Company (2021-2026)

    • 3.1.2 Global Perfluorodecalin for Ophthalmic Surgery Sales Market Share by Company (2021-2026)

  • 3.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Perfluorodecalin for Ophthalmic Surgery Revenue by Company (2021-2026)

    • 3.2.2 Global Perfluorodecalin for Ophthalmic Surgery Revenue Market Share by Company (2021-2026)

  • 3.3 Global Perfluorodecalin for Ophthalmic Surgery Sale Price by Company

  • 3.4 Key Manufacturers Perfluorodecalin for Ophthalmic Surgery Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Perfluorodecalin for Ophthalmic Surgery Product Location Distribution

    • 3.4.2 Players Perfluorodecalin for Ophthalmic Surgery Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Perfluorodecalin for Ophthalmic Surgery by Geographic Region

  • 4.1 World Historic Perfluorodecalin for Ophthalmic Surgery Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Perfluorodecalin for Ophthalmic Surgery Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Perfluorodecalin for Ophthalmic Surgery Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Perfluorodecalin for Ophthalmic Surgery Sales Growth

  • 4.4 APAC Perfluorodecalin for Ophthalmic Surgery Sales Growth

  • 4.5 Europe Perfluorodecalin for Ophthalmic Surgery Sales Growth

  • 4.6 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales Growth

• 5 Americas

  • 5.1 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Country

    • 5.1.1 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026)

    • 5.1.2 Americas Perfluorodecalin for Ophthalmic Surgery Revenue by Country (2021-2026)

  • 5.2 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021-2026)

  • 5.3 Americas Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Region

    • 6.1.1 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Region (2021-2026)

    • 6.1.2 APAC Perfluorodecalin for Ophthalmic Surgery Revenue by Region (2021-2026)

  • 6.2 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021-2026)

  • 6.3 APAC Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Perfluorodecalin for Ophthalmic Surgery by Country

    • 7.1.1 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026)

    • 7.1.2 Europe Perfluorodecalin for Ophthalmic Surgery Revenue by Country (2021-2026)

  • 7.2 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021-2026)

  • 7.3 Europe Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery by Country

    • 8.1.1 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Perfluorodecalin for Ophthalmic Surgery Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Perfluorodecalin for Ophthalmic Surgery

  • 10.3 Manufacturing Process Analysis of Perfluorodecalin for Ophthalmic Surgery

  • 10.4 Industry Chain Structure of Perfluorodecalin for Ophthalmic Surgery

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Perfluorodecalin for Ophthalmic Surgery Distributors

  • 11.3 Perfluorodecalin for Ophthalmic Surgery Customer

• 12 World Forecast Review for Perfluorodecalin for Ophthalmic Surgery by Geographic Region

  • 12.1 Global Perfluorodecalin for Ophthalmic Surgery Market Size Forecast by Region

    • 12.1.1 Global Perfluorodecalin for Ophthalmic Surgery Forecast by Region (2027-2032)

    • 12.1.2 Global Perfluorodecalin for Ophthalmic Surgery Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Perfluorodecalin for Ophthalmic Surgery Forecast by Type (2027-2032)

  • 12.7 Global Perfluorodecalin for Ophthalmic Surgery Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Alchimia srl

    • 13.1.1 Alchimia srl Company Information

    • 13.1.2 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.1.3 Alchimia srl Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Alchimia srl Main Business Overview

    • 13.1.5 Alchimia srl Latest Developments

  • 13.2 Bausch + Lomb

    • 13.2.1 Bausch + Lomb Company Information

    • 13.2.2 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.2.3 Bausch + Lomb Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Bausch + Lomb Main Business Overview

    • 13.2.5 Bausch + Lomb Latest Developments

  • 13.3 BVI Medical

    • 13.3.1 BVI Medical Company Information

    • 13.3.2 BVI Medical Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.3.3 BVI Medical Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 BVI Medical Main Business Overview

    • 13.3.5 BVI Medical Latest Developments

  • 13.4 Geuder AG

    • 13.4.1 Geuder AG Company Information

    • 13.4.2 Geuder AG Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.4.3 Geuder AG Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Geuder AG Main Business Overview

    • 13.4.5 Geuder AG Latest Developments

  • 13.5 Pharmpur

    • 13.5.1 Pharmpur Company Information

    • 13.5.2 Pharmpur Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.5.3 Pharmpur Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Pharmpur Main Business Overview

    • 13.5.5 Pharmpur Latest Developments

  • 13.6 Toomac Ophthalmic

    • 13.6.1 Toomac Ophthalmic Company Information

    • 13.6.2 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.6.3 Toomac Ophthalmic Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Toomac Ophthalmic Main Business Overview

    • 13.6.5 Toomac Ophthalmic Latest Developments

  • 13.7 Micromed srl

    • 13.7.1 Micromed srl Company Information

    • 13.7.2 Micromed srl Perfluorodecalin for Ophthalmic Surgery Product Portfolios and Specifications

    • 13.7.3 Micromed srl Perfluorodecalin for Ophthalmic Surgery Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Micromed srl Main Business Overview

    • 13.7.5 Micromed srl Latest Developments

• 14 Research Findings and Conclusion